Brian Berquist, PhD

SVP & Chief Development Officer at Wheeler Bio

Speaker

Dr. Berquist has over 20 years of industry, government, and academic research and development. Brian serves as SVP and Chief Development Officer for Wheeler Bio overseeing Cell Line, Process, Analytical, and Formulation Development. Prior to joining Wheeler, Brian was in positions of increasing responsibility at iBio in Bryan, Texas and commenced his tenure there as the Vice President of Process Development and Head of Platform and Technology Development. Brian was responsible for building the process development teams as well as the analytical development and characterization groups for IND enabling and early clinical development of therapeutics and vaccines for both internal programs as well as CDMO services clients.

He also had responsibility for innovation and continuous improvement of up- and downstream technologies. Brian initiated his industry career with Caliber Therapeutics with an emphasis on development of downstream purification processes, analytical characterization, scale-up, and technology transfer. Dr.

Berquist received his B.S. in Biochemistry and Molecular Biology, with a minor in Chemistry from the University of Massachusetts and his Ph.D. in Molecular Medicine from the University of Maryland School of Medicine where he graduated Summa cum laude. He followed with a post-doctoral fellowship in the Laboratory of Molecular Gerontology at the National Institute on Aging, a part of the National Institutes of Health.